Infusion Site Reactions: Classification in the Setting of Fosaprepitant Administration With Chemotherapy.

Clinical Journal of Oncology Nursing
Alexa N SegnaBevin Cohen

Abstract

Studies report a wide range of incidence and severity of infusion site adverse events (ISAEs) following fosaprepitant administration. The purposes of this study were (a) to determine the incidence of suspected extravasation in patients with cancer receiving fosaprepitant infusions with chemotherapy and (b) to determine whether the documented signs, symptoms, and management strategies aligned with the diagnostic criteria for extravasation versus non-extravasation ISAEs. Electronic health records were used to identify patients who received fosaprepitant infusion with chemotherapy and had documentation for suspected extravasation. Chart reviews were conducted for a sample of patients to determine whether documentation was consistent with extravasation. About 3% (n = 460 of 15,667) of patients who received fosaprepitant had documentation for suspected extravasation. Among a random sample of patients (N = 110) with suspected extravasation, 6% (n = 6) had documentation consistent with extravasation.

References

Jan 25, 2011·Seminars in Oncology Nursing·Lisa Schulmeister
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J A Pérez FidalgoUNKNOWN ESMO Guidelines Working Group
Feb 2, 2013·Clinical Journal of Oncology Nursing·Tulia Gonzalez
Jun 6, 2013·ISRN Dermatology·S Al-BennaJ Holley
Dec 5, 2013·Japanese Journal of Clinical Oncology·Emiko SakaidaYuichi Takiguchi
Jan 10, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A D LealCharles L Loprinzi
Jan 10, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jordan D LundbergRobert Wesolowski
Jun 27, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Livia T HegerovaCharles L Loprinzi
Mar 22, 2015·The Oncologist·Matti AaproDavid Warr
Jul 25, 2017·Clinical Journal of Oncology Nursing·Jeannette Jackson-RoseRobert David Rice
Nov 8, 2017·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Yuko MatsuiHiromi Sanada
Nov 8, 2017·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Sarah C GonçalvesGiseli R C Santos
Mar 21, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lee Schwartzberg
Apr 14, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Eric ChauRobert Wesolowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Allison BaxleyPatrick Medina
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Lesley Jones, Paul Coe
© 2021 Meta ULC. All rights reserved